Tarsus Pharmaceuticals (TARS.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov5

Tarsus Pharmaceuticals released FY2025 Q3 earnings on November 4 After-Market EST, actual revenue USD 118.7 M (forecast USD 115.22 M), actual EPS USD -0.2999 (forecast USD -0.3433)

00:00

Tarsus Pharmaceuticals released FY2025 9 Months Earnings on November 4 After-Market EST, with actual revenue of USD 299.69 M and EPS of USD -1.4139

00:00

Oct28

Tarsus Pharmaceuticals to Release FY2025 Q3 Earnings on November 4 After-Market EST, Forecast Revenue USD 115.22 M, EPS USD -0.3433

00:05

Oct9

Gerberry Recommends Healthcare Stocks, Tarsus Pharmaceuticals Earns Buy Rating

11:11

Oct3

Gerberry's Ratings on Healthcare Industry Stocks

11:21

Aug6

Tarsus Pharmaceuticals released FY2025 Q2 earnings on August 6 After-Market (EST), actual revenue USD 102.66 M (forecast USD 95.81 M), actual EPS USD -0.4801 (forecast USD -0.3766)

23:00